Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11714046rdf:typepubmed:Citationlld:pubmed
pubmed-article:11714046lifeskim:mentionsumls-concept:C0021311lld:lifeskim
pubmed-article:11714046lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:11714046lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:11714046lifeskim:mentionsumls-concept:C0543467lld:lifeskim
pubmed-article:11714046lifeskim:mentionsumls-concept:C1512910lld:lifeskim
pubmed-article:11714046lifeskim:mentionsumls-concept:C0007554lld:lifeskim
pubmed-article:11714046lifeskim:mentionsumls-concept:C0025872lld:lifeskim
pubmed-article:11714046lifeskim:mentionsumls-concept:C0250480lld:lifeskim
pubmed-article:11714046pubmed:issue9lld:pubmed
pubmed-article:11714046pubmed:dateCreated2001-11-20lld:pubmed
pubmed-article:11714046pubmed:abstractTextThe efficacy of piperacillin/tazobactam at 100/12.5 mg/kg every 8 h (35 patients) was compared to cefotaxime plus metronidazole at 50/7.5 mg/kg every 8 h (35 patients) in 70 children with intra-abdominal infections requiring surgery. Diagnoses were gangrenous or perforated appendicitis (n =56), peritonitis (n =12), and abscess (n =2). Clinical cure was observed in 35 of 35 evaluable patients treated with piperacilin/tazobactam and in 34 of 34 evaluable patients treated with cefotaxime plus metronidazole. Presumed bacteriological eradication was noted in 29 of 30 evaluable patients in the piperacillin/tazobactam group and in 31 of 31 evaluable patients in the cefotaxime plus metronidazole group. In this study, piperacillin/tazobactam was as effective as cefotaxime plus metronidazole for treating children with intra-abdominal infections requiring surgery.lld:pubmed
pubmed-article:11714046pubmed:languageenglld:pubmed
pubmed-article:11714046pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11714046pubmed:citationSubsetIMlld:pubmed
pubmed-article:11714046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11714046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11714046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11714046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11714046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11714046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11714046pubmed:statusMEDLINElld:pubmed
pubmed-article:11714046pubmed:monthSeplld:pubmed
pubmed-article:11714046pubmed:issn0934-9723lld:pubmed
pubmed-article:11714046pubmed:authorpubmed-author:KafetzisD ADAlld:pubmed
pubmed-article:11714046pubmed:authorpubmed-author:NikolaidisPPlld:pubmed
pubmed-article:11714046pubmed:authorpubmed-author:Androulakakis...lld:pubmed
pubmed-article:11714046pubmed:authorpubmed-author:MaltezouH CHClld:pubmed
pubmed-article:11714046pubmed:authorpubmed-author:DimitriouLLlld:pubmed
pubmed-article:11714046pubmed:authorpubmed-author:LebesiiEElld:pubmed
pubmed-article:11714046pubmed:issnTypePrintlld:pubmed
pubmed-article:11714046pubmed:volume20lld:pubmed
pubmed-article:11714046pubmed:ownerNLMlld:pubmed
pubmed-article:11714046pubmed:authorsCompleteYlld:pubmed
pubmed-article:11714046pubmed:pagination643-6lld:pubmed
pubmed-article:11714046pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11714046pubmed:meshHeadingpubmed-meshheading:11714046...lld:pubmed
pubmed-article:11714046pubmed:meshHeadingpubmed-meshheading:11714046...lld:pubmed
pubmed-article:11714046pubmed:meshHeadingpubmed-meshheading:11714046...lld:pubmed
pubmed-article:11714046pubmed:meshHeadingpubmed-meshheading:11714046...lld:pubmed
pubmed-article:11714046pubmed:meshHeadingpubmed-meshheading:11714046...lld:pubmed
pubmed-article:11714046pubmed:meshHeadingpubmed-meshheading:11714046...lld:pubmed
pubmed-article:11714046pubmed:meshHeadingpubmed-meshheading:11714046...lld:pubmed
pubmed-article:11714046pubmed:meshHeadingpubmed-meshheading:11714046...lld:pubmed
pubmed-article:11714046pubmed:meshHeadingpubmed-meshheading:11714046...lld:pubmed
pubmed-article:11714046pubmed:meshHeadingpubmed-meshheading:11714046...lld:pubmed
pubmed-article:11714046pubmed:meshHeadingpubmed-meshheading:11714046...lld:pubmed
pubmed-article:11714046pubmed:meshHeadingpubmed-meshheading:11714046...lld:pubmed
pubmed-article:11714046pubmed:meshHeadingpubmed-meshheading:11714046...lld:pubmed
pubmed-article:11714046pubmed:meshHeadingpubmed-meshheading:11714046...lld:pubmed
pubmed-article:11714046pubmed:meshHeadingpubmed-meshheading:11714046...lld:pubmed
pubmed-article:11714046pubmed:meshHeadingpubmed-meshheading:11714046...lld:pubmed
pubmed-article:11714046pubmed:meshHeadingpubmed-meshheading:11714046...lld:pubmed
pubmed-article:11714046pubmed:meshHeadingpubmed-meshheading:11714046...lld:pubmed
pubmed-article:11714046pubmed:meshHeadingpubmed-meshheading:11714046...lld:pubmed
pubmed-article:11714046pubmed:meshHeadingpubmed-meshheading:11714046...lld:pubmed
pubmed-article:11714046pubmed:meshHeadingpubmed-meshheading:11714046...lld:pubmed
pubmed-article:11714046pubmed:year2001lld:pubmed
pubmed-article:11714046pubmed:articleTitlePiperacillin/Tazobactam versus cefotaxime plus metronidazole for treatment of children with intra-abdominal infections requiring surgery.lld:pubmed
pubmed-article:11714046pubmed:affiliationUniversity of Athens Second Department of Pediatrics, P. & A. Kyriakou Children's Hospital, Athens, Greece.lld:pubmed
pubmed-article:11714046pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11714046pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:11714046pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:11714046pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11714046lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11714046lld:pubmed